Results 171 to 180 of about 577,051 (308)

End-Stage Renal Disease: Then and Now [PDF]

Mayo Clinic Proceedings, 1984
openaire   +2 more sources

A Circuit of Mechanically Regulated Transcription Factors Balances Regenerative and Fibrotic Memory of Mesenchymal Stromal Cells

Advanced Science, EarlyView.
Producing MSCs on rigid culture substrates induces a scar‐making phenotype, jeapordizing therapeutic success. ‘Tissue‐soft’ surfaces prevent MSC fibrogenesis and preserve regenerative traits. An epigenetic network, driven by HOXA11 and SALL1, maintains ‘soft memory’ by keeping chromatin open in relaxed MSCs, promoting anti‐fibrotic programs.
Fereshteh Sadat Younesi, Andrew E. Miller, Li Diao, Xinying Guo, Natalie Andonian, Elham Karimizadeh, Thomas H. Barker, Boris Hinz   +7 more
wiley   +1 more source

Fatal adenovirus meningoencephalitis in end stage renal disease patient

International Journal of Infectious Diseases, 2020
X.K. Cheong, C.L. Lau, L.S. Loong, M.K. Yin, F.W. Tajuruddin, P. Periyasamy, N. Kori   +6 more
doaj   +1 more source

Outcomes in end-stage renal disease dialysis patients with depression. [PDF]

BJPsych Open
Yang IN, Lu CL, Wang JJ, Hung MC, Chien CC.   +4 more
europepmc   +1 more source

Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors

Advanced Science, EarlyView.
This study reports the development of a fully humanized bispecific T cell engager targeting IL13RA2, a tumor‐associated antigen enriched in glioblastoma. This off‐the‐shelf immunotherapy drives potent, antigen‐dependent T cell activation and tumor killing, and prolongs survival in experimental GBM and other solid tumors models without detectable off ...
Joseph T. Duffy, Angela Martin‐Regalado, Benedikt E. Haupt, Jacob R. Pogue, Aditi Thakur, Manuel Fierro Cota, Markella Zannikou, Sol Misener, Vera P. Krymskaya, Kathleen McCortney, Jason Miska, Craig Horbinski, Dmitri Simberg, Maciej S. Lesniak, Charles D. James, Roger Stupp, Irina V. Balyasnikova   +16 more
wiley   +1 more source

Prevalence and Predictors of Pulmonary Hypertension in End-Stage Renal Disease: a Single-Center Cross-Sectional Study. [PDF]

Maedica (Bucur)
Neagu A, Capusa C, Zugravu A, Croitoru EL, Bogdan MA.   +4 more
europepmc   +1 more source

The Policy Debate on Patient Care Financing for Victims of End-Stage Renal Disease [PDF]

, 1976
Rettig, Richard A.
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Metabolic syndrome in end stage renal disease

Journal of Research in Medical Sciences, 2014
Mojgan Mortazavi, Shiva Seyrafian, Nafiseh Moein, Diana Taheri, Shahaboddin Dolatkhah   +4 more
doaj  

Enhancing end-stage renal disease outcome prediction: a multisourced data-driven approach. [PDF]

J Am Med Inform Assoc
Li Y, Padman R.
europepmc   +1 more source